Literature DB >> 16736351

Resistance to HIV infection.

M Marmor1, K Hertzmark, S M Thomas, P N Halkitis, M Vogler.   

Abstract

The biological correlates of an effective immune response that could contain or prevent HIV infection remain elusive despite substantial scientific accomplishments in understanding the interactions among the virus, the individual and the community. The observation that some individuals appear to possess resistance to HIV infection or its consequences has generated a host of epidemiologic investigations to identify biological or behavioral characteristics of these individuals. These data might hold the keys to developing appropriate strategies for mimicking the effective responses of those who appear immune. In this paper we review genetic mechanisms including the role of chemokines and their receptors, cytokines, host genetic immune response to HIV infection, local immune response correlating with behavioral variables, co-infection and immune based mechanisms that have been elucidated so far. We offer suggestions for how to use these observations as platforms for future research to further understand natural resistance to HIV infection through cohort studies, population genotype sampling, mathematical modeling of virus-host interactions and behavioral analyses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736351      PMCID: PMC1539443          DOI: 10.1007/s11524-005-9003-8

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  67 in total

1.  Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.

Authors:  H D Shin; C Winkler; J C Stephens; J Bream; H Young; J J Goedert; T R O'Brien; D Vlahov; S Buchbinder; J Giorgi; C Rinaldo; S Donfield; A Willoughby; S J O'Brien; M W Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 2.  The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.

Authors:  S J O'Brien; J P Moore
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

3.  Impact of natural chemokine receptor polymorphisms on perinatal transmission of human immunodeficiency virus type 1.

Authors:  L G Kostrikis
Journal:  Teratology       Date:  2000-05

4.  The role of theory in HIV prevention.

Authors:  M Fishbein
Journal:  AIDS Care       Date:  2000-06

5.  Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection.

Authors:  K S MacDonald; K R Fowke; J Kimani; V A Dunand; N J Nagelkerke; T B Ball; J Oyugi; E Njagi; L K Gaur; R C Brunham; J Wade; M A Luscher; P Krausa; S Rowland-Jones; E Ngugi; J J Bwayo; F A Plummer
Journal:  J Infect Dis       Date:  2000-05-08       Impact factor: 5.226

6.  Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.

Authors:  E E Nakayama; Y Hoshino; X Xin; H Liu; M Goto; N Watanabe; H Taguchi; A Hitani; A Kawana-Tachikawa; M Fukushima; K Yamada; W Sugiura; S I Oka; A Ajisawa; H Sato; Y Takebe; T Nakamura; Y Nagai; A Iwamoto; T Shioda
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

Authors:  J P Ioannidis; P S Rosenberg; J J Goedert; L J Ashton; T L Benfield; S P Buchbinder; R A Coutinho; J Eugen-Olsen; T Gallart; T L Katzenstein; L G Kostrikis; H Kuipers; L G Louie; S A Mallal; J B Margolick; O P Martinez; L Meyer; N L Michael; E Operskalski; G Pantaleo; G P Rizzardi; H Schuitemaker; H W Sheppard; G J Stewart; I D Theodorou; H Ullum; E Vicenzi; D Vlahov; D Wilkinson; C Workman; J F Zagury; T R O'Brien
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

8.  T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission.

Authors:  L Kuhn; A Coutsoudis; D Moodley; D Trabattoni; N Mngqundaniso; G M Shearer; M Clerici; H M Coovadia; Z Stein
Journal:  AIDS       Date:  2001-01-05       Impact factor: 4.177

9.  The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission.

Authors:  K S MacDonald; J E Embree; N J Nagelkerke; J Castillo; S Ramhadin; S Njenga; J Oyug; J Ndinya-Achola; B H Barber; J J Bwayo; F A Plummer
Journal:  J Infect Dis       Date:  2000-12-11       Impact factor: 5.226

10.  Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.

Authors:  L Bélec; P D Ghys; H Hocini; J N Nkengasong; J Tranchot-Diallo; M O Diallo; V Ettiègne-Traore; C Maurice; P Becquart; M Matta; A Si-Mohamed; N Chomont; I M Coulibaly; S Z Wiktor; M D Kazatchkine
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226

View more
  18 in total

Review 1.  Protective alleles and modifier variants in human health and disease.

Authors:  Andrew R Harper; Shalini Nayee; Eric J Topol
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

2.  HIV infection and host genetic mutation among injecting drug-users of northeastern states of India.

Authors:  Kamalesh Sarkar; Santa Sabuj Das; Reshmi Pal; Baishali Bal; P Madhusudan; Sekhar Chakraborti
Journal:  J Health Popul Nutr       Date:  2010-04       Impact factor: 2.000

3.  A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice.

Authors:  Chioma M Okeoma; Ming Shen; Susan R Ross
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

Review 4.  Hepatitis G virus.

Authors:  Vasiliy Ivanovich Reshetnyak; Tatiana Igorevna Karlovich; Ljudmila Urievna Ilchenko
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

Review 5.  "Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches.

Authors:  Tanushree Malik; Gaurav Chauhan; Goutam Rath; R S R Murthy; Amit K Goyal
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  The Microbiological Context of HIV Resistance: Vaginal Microbiota and Mucosal Inflammation at the Viral Point of Entry.

Authors:  John J Schellenberg; Francis A Plummer
Journal:  Int J Inflam       Date:  2012-03-14

7.  Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.

Authors:  Geert Zegels; Geert Aa Van Raemdonck; Wiebren Aa Tjalma; Xaveer Wm Van Ostade
Journal:  Proteome Sci       Date:  2010-12-08       Impact factor: 2.480

Review 8.  What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

Authors:  Grant R Campbell; Erwann P Loret
Journal:  Retrovirology       Date:  2009-05-25       Impact factor: 4.602

9.  Association of HLA-A, B, DRB1 alleles and haplotypes with HIV-1 infection in Chongqing, China.

Authors:  Xia Huang; Hua Ling; Wei Mao; Xianbin Ding; Quanhua Zhou; Mei Han; Fang Wang; Lei Cheng; Hongyan Xiong
Journal:  BMC Infect Dis       Date:  2009-12-12       Impact factor: 3.090

10.  Chemokine Coreceptor-2 Gene Polymorphisms among HIV-1 Infected Individuals in Kenya.

Authors:  Dorcas Wachira; Raphael Lihana; Vincent Okoth; Alex Maiyo; Samoel Ashimosi Khamadi
Journal:  Dis Markers       Date:  2015-08-02       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.